Design and synthesis of 5-(5-nitrothiophen-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazole derivatives with improved solubility and potential antituberculosis activity.


Journal

Chemical biology & drug design
ISSN: 1747-0285
Titre abrégé: Chem Biol Drug Des
Pays: England
ID NLM: 101262549

Informations de publication

Date de publication:
01 2019
Historique:
received: 19 06 2018
revised: 02 08 2018
accepted: 04 08 2018
pubmed: 25 8 2018
medline: 7 11 2019
entrez: 25 8 2018
Statut: ppublish

Résumé

We report the design-synthesis of several nitrothiophene containing molecules as antituberculosis agents. The molecules were designed on the basis of previously reported nitrofuran molecules in our laboratory, and the α,β-unsaturated linker was modified to cyclized linker in order to overcome the challenge of low solubility and possible toxicity. The stereo-electronic properties such as HOMO, LUMO, and HOMO-LUMO gap along with other properties such as aqueous solvation energies and QPLogS values were studied. The designed molecules were synthesized and tested for in vitro antituberculosis activity, and some molecules were found to be highly active comparable to standard drugs. Further, the aqueous solubility was determined using visual inspection method and the designed molecules were found to be more soluble than their chalcone counterparts. Cytotoxicity studies were performed and the molecules were found to be non-cytotoxic. Electroanalytical studies proved nitro reduction as the mechanism of action for these molecules. Thus, this study provides potential nitrothiophene containing hits with improved solubility and reduced chances of toxicity.

Identifiants

pubmed: 30142699
doi: 10.1111/cbdd.13386
doi:

Substances chimiques

Antitubercular Agents 0
Pyrazoles 0

Types de publication

Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-88

Informations de copyright

© 2018 John Wiley & Sons A/S.

Auteurs

Mihir Khambete (M)

Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

Harish Kundaikar (H)

Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

Archana Raju (A)

Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

Sachin Lonkar (S)

Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

Mariam Degani (M)

Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

Mukti Kanta Ray (MK)

Tuberculosis Immunology and Immunoassay Development Section, Radiation Medicine Centre-BARC, Tata Memorial Hospital, Mumbai, India.

Articles similaires

Animals Hemiptera Insect Proteins Phylogeny Insecticides
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol
Alzheimer Disease Humans Regression Analysis Quantitative Structure-Activity Relationship Drug Design

Classifications MeSH